The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

Obesity and type 2 diabetes mellitus (T2DM) are attributed to a combination of genetic susceptibility and lifestyle factors. Their increasing prevalence necessitates further studies on modifiable causative factors and novel treatment options. The gut microbiota has emerged as an important contributor to the obesity—and T2DM—epidemic proposed to act by increasing energy harvest from the diet. Although obesity is associated with substantial changes in the composition and metabolic function of the gut microbiota, the pathophysiological processes remain only partly understood. In this review we will describe the development of the adult human microbiome and discuss how the composition of the gut microbiota changes in response to modulating factors. The influence of short‐chain fatty acids, bile acids, prebiotics, probiotics, antibiotics and microbial transplantation is discussed from studies using animal and human models. Ultimately, we aim to translate these findings into therapeutic pathways for obesity and T2DM in humans.

[1]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[2]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[4]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[5]  D. Meyer,et al.  The bifidogenic effect of inulin and oligofructose and its consequences for gut health , 2009, European Journal of Clinical Nutrition.

[6]  E. Zoetendal,et al.  High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota , 2008, Gut.

[7]  H. Flint,et al.  Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces , 2006, Applied and Environmental Microbiology.

[8]  Elaine Holmes,et al.  Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. , 2008, Journal of proteome research.

[9]  M. Krempf,et al.  Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes. , 2003, The Proceedings of the Nutrition Society.

[10]  C. Winckler,et al.  Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model. , 2001, Zeitschrift fur Gastroenterologie.

[11]  T. Matsuzaki,et al.  Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet‐induced obesity mice , 2011, Journal of applied microbiology.

[12]  Alyce Adams,et al.  Why is the Developed World Obese? , 2007, Annual review of public health.

[13]  J. Mathers,et al.  Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the α-glucosidase inhibitor acarbose , 2004, British Journal of Nutrition.

[14]  Jeremy K. Nicholson,et al.  Gut microbiota: a potential new territory for drug targeting , 2008, Nature Reviews Drug Discovery.

[15]  G. Abrams,et al.  Effect of the Normal Microbial Flora on Gastrointestinal Motility.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  D. Drucker,et al.  Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor , 2006, Diabetes.

[17]  Elaine Holmes,et al.  Probiotic Modulation of Symbiotic Gut Microbial–host Metabolic Interactions in a Humanized Microbiome Mouse Model , 2022 .

[18]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[19]  P. Steenhout,et al.  Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. , 2008, The American journal of clinical nutrition.

[20]  B. Wostmann.  Intestinal bile acids and cholesterol absorption in the germfree rat. , 1973, The Journal of nutrition.

[21]  D. Raoult,et al.  The Increase of Lactobacillus Species in the Gut Flora of Newborn Broiler Chicks and Ducks Is Associated with Weight Gain , 2010, PloS one.

[22]  Gilbert Habib,et al.  Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity , 2010, PloS one.

[23]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[24]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[25]  D. Raoult,et al.  Growth-promoting effects of single-dose intragastrically administered probiotics in chickens , 2007, British poultry science.

[26]  D. Häussinger,et al.  Endocrine and paracrine role of bile acids. , 2008, World journal of gastroenterology.

[27]  Baoli Zhu,et al.  Human gut microbiome: the second genome of human body , 2010, Protein & Cell.

[28]  P. Dubuc,et al.  Age dependent effects of oxytetracycline in ob/ob mice , 1978, Diabetologia.

[29]  M. Camilleri,et al.  The role of peptide YY in integrative gut physiology and potential role in obesity , 2007, Current opinion in endocrinology, diabetes, and obesity.

[30]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[31]  P. B. Lynch,et al.  Relative Ability of Orally Administered Lactobacillus murinus To Predominate and Persist in the Porcine Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.

[32]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[33]  Rob Knight,et al.  High-fat diet determines the composition of the murine gut microbiome independently of obesity. , 2009, Gastroenterology.

[34]  E. Murphy,et al.  Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models , 2010, Gut.

[35]  E. Zoetendal,et al.  Metabolic effects of transplanting gut microbiota from lean donors to subjects with metabolic syndrome , 2010 .

[36]  M. Kleerebezem,et al.  Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance , 2009, Proceedings of the National Academy of Sciences.

[37]  A. Hosono,et al.  Antidiabetic Effect of Lactobacillus GG in Streptozotocin-induced Diabetic Rats , 2003, Bioscience, biotechnology, and biochemistry.

[38]  Han-Oh Park,et al.  Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats , 2010, The Journal of Microbiology.

[39]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[40]  W. D. de Vos,et al.  S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions , 2008, Proceedings of the National Academy of Sciences.

[41]  Hui-Young Lee,et al.  Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. , 2006, Biochimica et biophysica acta.

[42]  S. Rabot,et al.  Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  W. Vahjen,et al.  Effect of the probiotic Enterococcus faecium NCIMB10415 on cell numbers of total Enterococcus spp., E. faecium and E. faecalis in the intestine of piglets. , 2007, Current issues in intestinal microbiology.

[44]  D. Jonkers,et al.  The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon , 2006, Alimentary pharmacology & therapeutics.

[45]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[46]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[47]  Michiel Kleerebezem,et al.  High temporal and inter-individual variation detected in the human ileal microbiota. , 2010, Environmental microbiology.

[48]  E. Want,et al.  Colonization-Induced Host-Gut Microbial Metabolic Interaction , 2011, mBio.

[49]  Benjamin P. Westover,et al.  Glycan Foraging in Vivo by an Intestine-Adapted Bacterial Symbiont , 2005, Science.

[50]  Hilary G. Morrison,et al.  Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation , 2009, Infection and Immunity.

[51]  H. Harmsen,et al.  Analysis of the Fecal Microflora of Human Subjects Consuming a Probiotic Product Containing Lactobacillus rhamnosusDR20 , 2000, Applied and Environmental Microbiology.

[52]  J. Auwerx,et al.  Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 , 2007, Molecular and Cellular Biology.

[53]  R. Reimer,et al.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. , 2009, The American journal of clinical nutrition.

[54]  J. Gordon,et al.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Fabrice Armougom,et al.  Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients , 2009, PloS one.

[56]  M. Miyata,et al.  Enterobacteria Modulate Intestinal Bile Acid Transport and Homeostasis through Apical Sodium-Dependent Bile Acid Transporter (SLC10A2) Expression , 2011, Journal of Pharmacology and Experimental Therapeutics.

[57]  R. Rastall,et al.  Prebiotics and synbiotics: towards the next generation. , 2002, Current opinion in biotechnology.

[58]  R. Crittenden,et al.  Selection of a Bifidobacterium strain to complement resistant starch in a synbiotic yoghurt , 2001, Journal of applied microbiology.

[59]  A. Moran,et al.  Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract , 2011, Gut.

[60]  M. Miyata,et al.  Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression , 2009, Journal of Pharmacology and Experimental Therapeutics.

[61]  H. Miyoshi,et al.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.

[62]  H. Heick,et al.  The effect of oxytetracycline on insulin resistance in obese mice. , 1974, The Biochemical journal.

[63]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[64]  L. Groop,et al.  Genetics of type 2 diabetes. , 2011, Clinical chemistry.

[65]  A. Majkowska,et al.  Selection of probiotics and prebiotics for synbiotics and confirmation of their in vivo effectiveness , 2002 .

[66]  G. Gibson,et al.  Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome , 2009, Alimentary pharmacology & therapeutics.

[67]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  I. Rowland,et al.  Resistant starch modifies gut microflora and microbial metabolism in human flora‐associated rats inoculated with faeces from Italian and UK donors , 1999, Journal of applied microbiology.

[69]  B. Wostmann,et al.  Analysis of bile acids in conventional and germfree rats. , 1976, Journal of lipid research.

[70]  J. Parkhill,et al.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.

[71]  H. Heick,et al.  Oxytetracycline Treatment Improves the Response to Insulin in the Spontaneously Diabetic (BB) Rat , 1982, Diabetes.

[72]  K. Westerterp,et al.  Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake , 2011, British Journal of Nutrition.

[73]  H. Ashrafian,et al.  Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk , 2011, Gut.

[74]  S. C. Lee,et al.  Increase of intestinal Bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. , 1999, Journal of dairy science.

[75]  S. Simpson.  Of Mice . . . , 2004, Science.

[76]  C. Edwards,et al.  Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? , 2006, The British journal of nutrition.

[77]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[78]  Patrice D Cani,et al.  Oligofructose promotes satiety in healthy human: a pilot study , 2006, European Journal of Clinical Nutrition.

[79]  G. Gibson,et al.  Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy. , 2005, Current pharmaceutical design.

[80]  I. Young,et al.  Lipid metabolism. , 2002, Current opinion in lipidology.

[81]  Cecilia Jernberg,et al.  Long-term impacts of antibiotic exposure on the human intestinal microbiota. , 2010, Microbiology.

[82]  Colin Hill,et al.  Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome , 2008, Proceedings of the National Academy of Sciences.

[83]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[84]  M. Blaut,et al.  Absence of intestinal microbiota does not protect mice from diet-induced obesity , 2010, British Journal of Nutrition.

[85]  P. Hylemon,et al.  Regulation of sterol 12α-hydroxylase and cholic acid biosynthesis in the rat , 2000 .

[86]  J. Bartlett.  Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.

[87]  H. Szajewska,et al.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.

[88]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[89]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[90]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[91]  L. T. Angenent,et al.  Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? , 2004, Nature Immunology.

[92]  R. Yamazaki,et al.  Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. , 1997, Endocrine journal.

[93]  W. Walker,et al.  Protective nutrients and bacterial colonization in the immature human gut. , 1999, Advances in pediatrics.

[94]  M. Yamaguchi,et al.  Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor , 2010, Journal of Lipid Research.

[95]  L. Duffy,et al.  In Vivo Effects of Bifidobacteria and Lactoferrin on Gut Endotoxin Concentration and Mucosal Immunity in Balb/c Mice , 2004, Digestive Diseases and Sciences.

[96]  Elaine Holmes,et al.  Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes , 2008, Molecular systems biology.

[97]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[98]  W. Verstraete,et al.  Combined use of Lactobacillus reuteri and soygerm powder as food supplement , 2001, Letters in applied microbiology.

[99]  T. Sørensen,et al.  Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics , 2011, International Journal of Obesity.

[100]  X. Hua,et al.  Inter-species transplantation of gut microbiota from human to pigs , 2007, The ISME Journal.

[101]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[102]  G. Reid,et al.  Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. , 2005, FEMS microbiology ecology.

[103]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[104]  M. Kleerebezem,et al.  Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways , 2010, Proceedings of the National Academy of Sciences.

[105]  R. Mackie,et al.  Developmental microbial ecology of the neonatal gastrointestinal tract. , 1999, The American journal of clinical nutrition.

[106]  H. Yadav,et al.  Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. , 2007, Nutrition.

[107]  W. Silen,et al.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. , 1958, Surgery.

[108]  S. Fuentes,et al.  Administration of Lactobacillus casei and Lactobacillus plantarum affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure. , 2008, Research in microbiology.

[109]  J. Clemente,et al.  Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.

[110]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[111]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[112]  K. Jeejeebhoy.  Short bowel syndrome: a nutritional and medical approach. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[113]  M. Roberfroid.  Prebiotics: the concept revisited. , 2007, The Journal of nutrition.

[114]  Jonathan A. Eisen,et al.  Human gut microbiome adopts an alternative state following small bowel transplantation , 2009, Proceedings of the National Academy of Sciences.

[115]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[116]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[117]  P. Gérard,et al.  Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion. , 2004, FEMS microbiology ecology.

[118]  D. Naslain,et al.  Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. , 2009, The American journal of clinical nutrition.

[119]  W. Verstraete,et al.  Influence of a synbiotic mixture consisting of Lactobacillus acidophilus 74-2 and a fructooligosaccharide preparation on the microbial ecology sustained in a simulation of the human intestinal microbial ecosystem (SHIME reactor) , 2000, Applied Microbiology and Biotechnology.